Last updated
Revenue
R&D Expenses
Operating CF
Total Assets
Total Liabilities
Equity
Shares Out.
D/E Ratio
Dilution Watch
Financials
52W LOW $11.6552W HIGH $18.61
Volume
27.84 M
Value Traded
23.73 M
Short % Float
1.11%
Cash Data
- Monthly Burn
- Burn Trend
- Dilution Risk
- SEC Filing
Key Stats
Market Cap
2.03 B
EPS (TTM)
1.16
P/E Ratio
14.13
Ent. Value
5.20 B
Total Shares
123.94 M
Float Shares
103.99 M
Insiders
14.12%
Institutions
81.78%
Upcoming Catalysts
FDA decisions, readouts and PDUFA dates · scored by probability of approval
| Catalyst | Drug / Treatment | Stage | Prob. of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | Small Molecule | Oncology | - |
PoA blends historical approval base rates, trial design score and FDA review track record.
SEM Catalyst Timeline
Dated clinical, regulatory and corporate events for SELECT MEDICAL HOLDINGS CORP
Catalyst Timeline
Dated clinical, regulatory & corporate events for SELECT MEDICAL HOLDINGS CORP
2Total events
0Upcoming
2Tier-1 (high impact)
2026 to 2026Coverage
Past FDA Catalysts and PDUFA Decisions
How SEM actually traded into and out of each decision
| Date | Drug | Catalyst | Stage | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|
| - | Example Drug | Phase 3 data readout | Phase 3 |
Reaction: 30 trading days around the event · Event Move: close to close on decision day · Best Trade: peak run-up from entry 10 days before the decision
Drug Pipeline Intelligence
No drug pipeline
SELECT MEDICAL HOLDINGS CORP is a services and tools company (CRO, lab tools or healthcare services). The clinical trials it takes part in test other companies' drugs, so it has no drug pipeline of its own to score.
Clinical Trial Results
Readouts, endpoints and source filings for every SEM program
Inside Trades
| Insider | Side | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Scully ThomasDirector | Disposition | -103,424 | $16.50 | 06/30/2026 |
Hedge Fund 13F Activity
Hedge Funds invested in SEM
| Fund | % of Portfolio | Current MV | Shares Owned | Activity |
|---|---|---|---|---|
| PROSIGHT MANAGEMENT, LP | 3.2 % (23.1 %) | 15.37 M | 1.04 M | 18.31% ( 160.17 K) |
SEM Institutional Ownership Trends
Options Data
Option Volume
Open Interest
Call OI
Put OI
Put-Call Ratio
OI 30-day avg
Today vs avg
Option Volume
Call Vol
Put Vol
Put-Call Ratio
Vol 30-day avg
Today vs avg
Option Chain Statistics
| Expiry | Call Vol | Put Vol | Vol P/C | Call OI | Put OI | OI P/C | IV Call | IV Call OI-Wtd | IV Call Vol-Wtd | IV Put | IV Put OI-Wtd | IV Put Vol-Wtd |
|---|
Real-Time Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last | Vol | OI | Last | Vol | OI | |
| No data available | ||||||
Calls vs Puts by Expiry
CallsPutsLog scale
Competitive positioning
How SEM ranks across every disease it competes in
Competitive Position is a premium feature
See how SEM ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trialSEM News
About SELECT MEDICAL HOLDINGS CORP
HeadquartersC/O SELECT MEDICAL CORP, MECHANICSBURG, PA, 17055
BIOPHARMAWATCH ELITE PLUS
Trade the next SEM catalyst before the market reprices
Every FDA decision, PoA score, 13F move and dilution flag on this page, for 1,100+ biotech tickers. From $19/mo billed annually.
Cancel anytime